SEC Comment Letter 0000000000-23-010105 to Syra Health Corp (SYRA) (CIK 0001922335) (SYRA)
Syra Health Corp (SYRA) (CIK 0001922335)
Date: Sept. 13, 2023 · CIK: 0001922335 · Accession: 0000000000-23-010105
AI Filing Summary & Sentiment
File numbers found in text: 333-271622
Letter
United States securities and exchange commission logo September 12, 2023 Deepika Vuppalanchi Chief Executive Officer Syra Health Corp 1119 Keystone Way N. #201 Carmel, IN 46032 Re:Syra Health Corp Amendment No. 4 to Registration Statement on Form S-1 Filed September 5, 2023 File No. 333-271622 Dear Deepika Vuppalanchi: We have reviewed your amended registration statement and have the following comments. In some of our comments, we may ask you to provide us with information so we may better understand your disclosure. Please respond to this letter by amending your registration statement and providing the requested information. If you do not believe our comments apply to your facts and circumstances or do not believe an amendment is appropriate, please tell us why in your response. After reviewing any amendment to your registration statement and the information you provide in response to these comments, we may have additional comments. Amendment No. 4 to Registration Statement on Form S-1 filed September 5, 2023 Capitalization, page 31 1.Please explain your calculation of pro forma as adjusted cash of $6,376,959 or revise as necessary.
FirstName LastNameDeepika Vuppalanchi Comapany NameSyra Health Corp September 12, 2023 Page 2 FirstName LastName Deepika Vuppalanchi Syra Health Corp September 12, 2023 Page 2 You may contact Scott Stringer at 202-551-3272 or Joel Parker at 202-551-3651 if you have questions regarding comments on the financial statements and related matters. Please contact Brian Fetterolf at 202-551-6613 or Erin Jaskot at 202-551-3442 with any other questions. Sincerely, Division of Corporation Finance Office of Trade & Services cc: Jeffrey Fessler
Show Raw Text
United States securities and exchange commission logo
September 12, 2023
Deepika Vuppalanchi
Chief Executive Officer
Syra Health Corp
1119 Keystone Way N. #201
Carmel, IN 46032
Re:Syra Health Corp
Amendment No. 4 to Registration Statement on Form S-1
Filed September 5, 2023
File No. 333-271622
Dear Deepika Vuppalanchi:
We have reviewed your amended registration statement and have the following
comments. In some of our comments, we may ask you to provide us with information so we
may better understand your disclosure.
Please respond to this letter by amending your registration statement and providing the
requested information. If you do not believe our comments apply to your facts and
circumstances or do not believe an amendment is appropriate, please tell us why in your
response.
After reviewing any amendment to your registration statement and the information you
provide in response to these comments, we may have additional comments.
Amendment No. 4 to Registration Statement on Form S-1 filed September 5, 2023
Capitalization, page 31
1.Please explain your calculation of pro forma as adjusted cash of $6,376,959 or revise as
necessary.
FirstName LastNameDeepika Vuppalanchi
Comapany NameSyra Health Corp
September 12, 2023 Page 2
FirstName LastName
Deepika Vuppalanchi
Syra Health Corp
September 12, 2023
Page 2
You may contact Scott Stringer at 202-551-3272 or Joel Parker at 202-551-3651 if you
have questions regarding comments on the financial statements and related matters. Please
contact Brian Fetterolf at 202-551-6613 or Erin Jaskot at 202-551-3442 with any other questions.
Sincerely,
Division of Corporation Finance
Office of Trade & Services
cc: Jeffrey Fessler